Hexarelin: A Research Peptide Overview
Hexarelin is a synthetic hexapeptide within the growth hormone-releasing peptide (GHRP) family. Its primary sequence—L-histidyl-D-2-naphthylalanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide—confers a molecular weight of approximately 887 Daltons and yields a stable, water-soluble lyophilized powder suitable for laboratory handling. Structurally, the inclusion of D-amino acid residues and a non-proteinogenic naphthylalanine moiety enhances resistance to enzymatic degradation, a property that has made Hexarelin a useful probe in endocrine research settings.
In receptor pharmacology studies, Hexarelin acts as a potent agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a), the same receptor activated by endogenous ghrelin. Investigators employ Hexarelin in in vitro binding and functional assays to characterize GHS-R1a signaling pathways, including calcium mobilization and downstream kinase activation. In in vivo laboratory models—most commonly rodent species—Hexarelin is used to dissect the neuroendocrine control of growth hormone (GH) release, as well as to explore complex interactions between ghrelin receptor activation and metabolic regulation. Research protocols have documented concentration-dependent stimulation of pituitary GH secretion, measurable via immunoassay, without extrapolation to therapeutic contexts. All applications are strictly confined to in vitro and in vivo laboratory research; this compound is not intended, approved, or suitable for diagnostic procedures, human consumption, or veterinary administration.
Factors Influencing Hexarelin Wholesale Price per Gram
When procurement specialists and laboratory managers evaluate the Hexarelin wholesale price per gram, they encounter a pricing structure driven by several interconnected technical and commercial variables. Understanding these factors enables informed budgeting and supplier selection without compromising the integrity of research workflows.
The foremost determinant is the chemical purity of the finished lyophilized product. Reputable manufacturers employ reverse-phase high-performance liquid chromatography (RP-HPLC) to achieve a minimum purity threshold, often exceeding 98%, and verify the molecular identity via mass spectrometry. The degree of purification, the number of purification steps, and the stringency of quality control each add incremental cost that is reflected in the per-gram quote. In parallel, synthesis complexity plays a role: although Hexarelin is a relatively short peptide, the incorporation of D‑2‑naphthylalanine requires specialised protected amino acid derivatives and optimised coupling conditions, which can marginally raise raw material and process development expenses. These upfront costs are frequently amortised over large production runs, meaning that the scale of synthesis directly influences the base price before any volume discounts are applied.
Commercial terms further shape the final figure. Transaction size—whether a single gram, a multi‑gram package, or a contract for periodic supply—shifts the price per unit substantially. Supplier geography, logistics, customs clearance fees, and adherence to quality management standards such as ISO 9001 or Good Manufacturing Practice (GMP) guidelines constitute additional cost layers. Facilities maintaining ISO-certified cleanrooms and conducting rigorous in-process testing typically quote higher, reflecting the investment in quality assurance that safeguards batch-to-batch consistency. Collectively, these elements mean that two research groups might observe notably different wholesale per-gram rates even for material of identical nominal purity.
Purity and Quality Specifications
Modern research peptides suppliers ordinarily characterise Hexarelin by its purity percentage as determined by RP-HPLC at a wavelength of 220 nm. The industry benchmark for standard research-grade material is ≥99% purity, with some producers delivering lyophilised product exceeding 99.5%. Each shipment should be accompanied by a comprehensive Certificate of Analysis (CoA) that includes, at a minimum, the HPLC chromatogram, the net peptide content, the mass spectrum confirming the correct molecular ion, and residual solvent data where applicable. This documentation enables the receiving laboratory to verify that the material meets the predetermined specifications before incorporating it into sensitive assays.
It is possible to source Hexarelin of lower declared purity, for example in the 95–98% range, at a reduced per-gram price. However, any cost saving must be weighed against the potential requirement for in-house re‑purification, which consumes solvents, column supplies, and technician time. Contaminants or sequence-truncated by‑products, even at low levels, can confound receptor-binding experiments or introduce artefacts in cell-based assays. Consequently, the majority of academic and industrial research buyers opt for the ≥99% purity grade, and the Hexarelin wholesale price per gram for this tier is the most widely referenced benchmark in procurement discussions.
Volume Discounts and Bulk Orders
Volume-based pricing tiers are a standard practice among peptide manufacturers and distributors. A typical structure might offer discrete pricing for quantities of 1 gram, 5 grams, 10 grams, and 25 grams, with per-gram rates declining markedly as the order size increases. As an illustration, publicly available supplier catalogues suggest that a single gram of ≥99% Hexarelin may be listed in the range of USD 65–90, whereas a 10‑gram purchase can bring the per-gram figure into a USD 40–60 bracket, representing a discount of roughly 20–35%. For laboratories with sustained, predictable consumption—such as those running longitudinal metabolic studies or receptor mapping projects—contracts that guarantee a minimum annual volume may unlock even more favourable unit pricing.
Beyond off‑the‑shelf stock, many suppliers offer custom synthesis arrangements. Under such agreements, a dedicated production run is scheduled exclusively for the customer, often yielding a lower cost per gram when the total order exceeds several tens of grams. Custom synthesis also permits tailoring of specific parameters, such as salt form (acetate or trifluoroacetate), packaging format, or inclusion of additional analytical tests. Procurement teams should evaluate total landed cost, including shipping, insurance, and any applicable import duties, when comparing bulk offers across suppliers.
Current Market Trends for Hexarelin Pricing
The wholesale market for Hexarelin has exhibited relative price stability over recent reporting periods, buoyed by consistent demand from academic endocrinology laboratories, pharmaceutical discovery units, and contract research organisations. Because the compound has been utilised in bench research for several decades, the synthetic routes are well established, and the number of competent manufacturers has grown, particularly in regions with advanced chemical production infrastructure. This competitive landscape tends to compress margins and keep the Hexarelin wholesale price per gram within a predictable corridor.
While fluctuations in the cost of protected amino acids, high-purity solvents, and chromatographic media occur, their impact on the final product price has been modest. Many manufacturers maintain buffer stocks of key precursors, smoothing out short‑term volatility. Additionally, improvements in solid‑phase peptide synthesis technology, including automated microwave-assisted synthesis and continuous‑flow purification, have incrementally lowered production costs. As a result, wholesale prices have tended to trend slightly downward or sideways in real terms, rather than spiking, making budget forecasting reasonably straightforward for research programmes.
Sourcing Hexarelin for Research Use
Selecting a supplier for Hexarelin requires careful verification of technical credentials and regulatory compliance. First, confirm that the vendor provides a CoA generated from independent, third‑party analytics rather than solely in‑house testing. The CoA should be lot‑specific and traceable to the exact vial received. When feasible, cross‑reference the batch number with any publicly available community databases or peer‑reported results, though such repositories are informal.
Examine the product labelling and accompanying documentation for the phrase “For laboratory research use only” or its legal equivalent. Legitimate suppliers will not make any express or implied claims regarding suitability for human or animal application. Absence of such disclaimers, or the presence of language suggesting any therapeutic potential, should be considered a red flag that the supplier may not be operating within the accepted regulatory framework.
Price comparison across multiple reputed vendors is a sensible practice, but the lowest list price is not always the best value. Scrutinise shipping charges, minimum order requirements, handling fees, and payment terms. Some suppliers levy substantial surcharges for cold-chain logistics even though lyophilised Hexarelin is stable at ambient temperature for short transit periods; others bundle these costs into the per‑gram rate. Currency exchange rates can also affect the final invoice, particularly for international transactions. Building a long‑term relationship with one or two qualified suppliers can yield dividends in the form of expedited fulfilment, preferential access to newly synthesised lots, and the ability to negotiate customised pricing schedules based on projected consumption.
Compliance and Regulatory Considerations
Hexarelin is not approved by the U.S. Food and Drug Administration, the European Medicines Agency, or any analogous regulatory body for diagnostic, prophylactic, or any other in‑human or in‑animal use. Every purchase order, commercial invoice, and shipping manifest must unambiguously identify the product as a research chemical and must state the end‑use as laboratory investigation. Some jurisdictions require an end‑user declaration form to be completed and filed with customs, certifying that the material will be handled exclusively within a legitimate research institution and will not be diverted.
Buyers bear the responsibility of ascertaining the importation status of Hexarelin in their own country. While many nations permit the import of research peptides without an additional license provided they are not destined for clinical application, others classify certain peptide sequences as controlled precursors or potentially hazardous substances, necessitating permits. Consulting local trade authorities or the supplier’s regulatory affairs team early in the procurement process helps avoid delays or rejection at the border. Suppliers who adhere to GMP-like principles for peptide synthesis—encompassing personnel training, equipment qualification, environmental monitoring, and thorough documentation—deliver an extra measure of confidence that the product is free from biological contaminants and endotoxins, an essential consideration for cell‑based or animal research. Selecting such a partner, even if the initial per‑gram cost is slightly higher, often reduces downstream experimental variability.
Research use only: The information presented in this article is intended solely for educational and procurement‑related guidance within the scientific community. Hexarelin is a laboratory‑grade peptide designed exclusively for in vitro and in vivo research purposes. It is not manufactured or approved for human or veterinary application, nor for diagnostic or therapeutic procedures. Any purchasing entity must ensure full compliance with all applicable local, national, and international regulations governing research chemicals.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
